Tacrine en es it fr

Tacrine Brand names, Tacrine Analogs

Tacrine Brand Names Mixture

  • No information avaliable

Tacrine Chemical_Formula


Tacrine RX_link


Tacrine fda sheet

Tacrine msds (material safety sheet)

Tacrine MSDS

Tacrine Synthesis Reference

No information avaliable

Tacrine Molecular Weight

198.264 g/mol

Tacrine Melting Point

183.5 oC

Tacrine H2O Solubility

217 mg/L

Tacrine State


Tacrine LogP


Tacrine Dosage Forms

No information avaliable

Tacrine Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Tacrine Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Tacrine Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Tacrine side effects and Toxicity

No information avaliable

Tacrine Patient Information

No information avaliable

Tacrine Organisms Affected

Humans and other mammals